Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1Myeloid 1

Conditions

Papillomavirus Infections 1Neoplasm Metastasis 1Lymphohistiocytosis, Hemophagocytic 1

Interventions

Paclitaxel 337pembrolizumab 332Carboplatin 330Cisplatin 277Gemcitabine 264Docetaxel 251Bevacizumab 239Nivolumab 230Pemetrexed 211Rituximab 183Dexamethasone 183Cyclophosphamide 169Capecitabine 169Trastuzumab 149Fluorouracil 147Ipilimumab 121atezolizumab 118Prednisone 117Erlotinib Hydrochloride 116Oxaliplatin 109Cetuximab 104Sunitinib 101Leucovorin 97Doxorubicin 97Lenalidomide 93Irinotecan 89130-nm albumin-bound paclitaxel 84durvalumab 77Bortezomib 77Azacitidine 73

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Has results × Data Collection × Clear all
NCT02312960 2025-03-25

Radium-223 Dichloride Long-term Follow-up Program

Bayer

Phase 4 Completed
255 enrolled 31 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT03259230 2024-09-19

Evaluation of IFNγ and Inflammatory Mediators in Patients With Malignancy-Associated Hemophagocytic Lymphohistiocytosis

Swedish Orphan Biovitrum

Completed
40 enrolled 43 charts
Myeloid

Lymphohistiocytosis, Hemophagocytic

NCT01101542 2018-07-23

Evaluation of Safety of a Vaccine Against Cervical Cancer in Healthy Korean Females

GlaxoSmithKline

Completed
3,091 enrolled 19 charts

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡